Author

Jeana Cromer

Observed names: J. Cromer, Jeana N. Cromer

Institutions: Mayo Clinic, University Hospitals of Cleveland, Henry Ford Hospital, Dana-Farber Cancer Institute, Wake Forest University, University of Arkansas for Medical Sciences

Observed institutions: St. Jude Children's Research Hospital, Mayo Clinic, Medical College of Wisconsin, University Hospitals of Cleveland, Henry Ford Hospital, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, National Cancer Institute, Loyola Medicine, University of Arizona Cancer Center, Wake Forest University, University of Arkansas for Medical Sciences

OpenAlex ID: A5033851395

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

1999 · B. Barlogie, S. Jagannath, et al. · Blood · 502

Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321

2006 · Bart Barlogie, Robert A. Kyle, et al. · Journal of Clinical Oncology · 495

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

1999 · B. Barlogie, S. Jagannath, et al. · Blood · 479

Thalidomide in the management of multiple myeloma

2001 · Bart Barlogie, Maurizio Zangari, et al. · Seminars in Hematology · 93

High-Dose Melphalan With Autotransplantation for Refractory Multiple Myeloma: Results of a Southwest Oncology Group Phase II Trial

1999 · David H. Vesole, John J. Crowley, et al. · Journal of Clinical Oncology · 78

Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation

2003 · Allen C Sherman, Elizabeth Ann Coleman, et al. · Supportive Care in Cancer · 29

Thalidomide in the management of multiple myeloma

2001 · Bart Barlogie, Maurizio Zangari, et al. · Seminars in Hematology · 12

Works count: 7

Citation count: 1,688

H-index: 7

I10-index: 7